Result: Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2021

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Leukemia. - 35 (2021) , 3551–3560, ISSN: 1476-5551

*DOI*:

10.1038/s41375-021-01276-4

*Result*: Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT